Cargando…

A model of the natural history of screen-detected prostate cancer

Detalles Bibliográficos
Autores principales:	Metcalfe, C, Lane, J A, Hamdy, F, Neal, D, Donovan, J L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360718/ https://www.ncbi.nlm.nih.gov/pubmed/17003784 http://dx.doi.org/10.1038/sj.bjc.6603368

Ejemplares similares

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival
por: Parker, C, et al.
Publicado: (2006)

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
por: Gilbert, Rebecca, et al.
Publicado: (2018)

The Natural History of an Eponym: The Malloy-Evelyn Method
por: Kricka, Larry J., et al.
Publicado: (2020)

Men’s knowledge and attitudes towards dietary prevention of a prostate cancer diagnosis: a qualitative study
por: Horwood, Jeremy P, et al.
Publicado: (2014)

Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening
por: Pashayan, N, et al.
Publicado: (2009)

Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study
por: Metcalfe, C, et al.
Publicado: (2009)

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
por: Sanghera, S., et al.
Publicado: (2020)

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result
por: Macefield, R C, et al.
Publicado: (2010)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
por: Rosario, Derek J, et al.
Publicado: (2012)

Natural history of COVID-19: back to basics
por: Zayet, S., et al.
Publicado: (2020)

Prostate volume and its influence on clinical parameters in prostate cancer detection
por: Stephan, Carsten, et al.
Publicado: (2023)

Re: Geriatric 8 screening of frailty in patients with prostate cancer
por: Sugimura, Rumiko, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial
por: Keeney, Edna, et al.
Publicado: (2022)

Comment on ‘Characteristics and screening history of women diagnosed with cervical cancer aged 20–29'
por: Herbert, A, et al.
Publicado: (2014)

Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population
por: Wei, Han-Min, et al.
Publicado: (2015)

Response to comment on ‘Characteristics and screening history of women diagnosed with cervical cancer aged 20–29'
por: Castanon, A, et al.
Publicado: (2014)

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study
por: Catto, J W F, et al.
Publicado: (2011)

Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation
por: Devos, David, et al.
Publicado: (2009)

Natural history of cerebrotendinous xanthomatosis: a paediatric disease diagnosed in adulthood
por: Degos, Bertrand, et al.
Publicado: (2016)

Men’s experiences of radiotherapy treatment for localized prostate cancer and its long-term treatment side effects: a longitudinal qualitative study
por: Sutton, E., et al.
Publicado: (2021)

The Diagnosis of Prostate Cancer
por: Schulz, Robert J.
Publicado: (2016)

Alcohol consumption and PSA-detected prostate cancer risk—A case-control nested in the ProtecT study
por: Zuccolo, Luisa, et al.
Publicado: (2013)

Natural history of MRI brain volumes in patients with neuronal ceroid lipofuscinosis 3: a sensitive imaging biomarker
por: Hochstein, Jan-Niklas, et al.
Publicado: (2022)

Patients with COVID-19 and Disguising on Travel History: A Challenge in Disease Screening
por: Joob, Beuy, et al.
Publicado: (2020)

ZHER2 Affibody as a Good Candidate for Detection of Metastatic Prostate Cancer
por: Nazari, Mahboobeh, et al.
Publicado: (2021)

Natural history of human Monkeypox in individuals attending a sexual health clinic in Milan, Italy
por: Moschese, Davide, et al.
Publicado: (2023)

Beyond familial risk: deriving risk‐adapted starting ages of screening among people with a family history of colorectal cancer
por: Chen, Xuechen, et al.
Publicado: (2023)

Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer
por: Ji, Jin, et al.
Publicado: (2021)

Reply: ‘Hand pattern indicates risk of prostate cancer’
por: Rahman, A A, et al.
Publicado: (2011)

Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy
por: Gilbert, Rebecca, et al.
Publicado: (2015)

Re: Determinants of participation in prostate cancer screening: A simple analytical framework to account for healthy-user bias
por: Tokudome, Shinkan
Publicado: (2015)

Breast Milk Pasteurization: Appropriate Assays to Detect HIV Inactivation
por: Chantry, Caroline J., et al.
Publicado: (2006)

Evolving Natural History of Metastatic Prostate Cancer
por: Nafissi, Nellie N, et al.
Publicado: (2020)

Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial
por: Walsh, Eleanor I., et al.
Publicado: (2016)

The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer
por: Castro, Elena, et al.
Publicado: (2016)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
por: Harrison, Sean, et al.
Publicado: (2020)

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study
por: Dimitropoulou, P, et al.
Publicado: (2011)

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
por: Pashayan, Nora, et al.
Publicado: (2015)

The value of virtual natural history collections for botanical instruction in these times of the COVID-19 pandemic
por: Cota-Sánchez, J. Hugo
Publicado: (2020)

Cost-effectiveness of population-based screening for colorectal cancer
por: O'Mahony, J F
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hbq88ed2hhq2ge54p37lafq1nu